Refractive Outcomes and Ocular Biometry of Two Swept-Source Optical Coherence Tomography-Based Biometers With Segmental or Equivalent Refractive Indices (ORION): A Non-Inferiority Randomized Clinical Trials

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Cataract surgery represents a common surgical intervention, encompassing the extraction of the opaque natural crystalline lens, followed by the substitution with an artificial intraocular lens (IOL). To ascertain an IOL possessing optimal power, antecedent to the surgery, preoperative evaluations are conducted through the utilization of a biometric devices. Diverse categories of these instruments are accessible, each harnessing distinct optical methodologies or mathematical algorithms to ascertain the most fitting IOL power. The principal objective of this study was to evaluate the ocular biometry and the predictive precision outcome of a biometer that uses standard keratometry to the prediction accuracy of another biometer that uses Total Keratometry.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 85
Healthy Volunteers: t
View:

• • Patients with cataract and/or presbyopia who will undergo intraocular lens implantation.

Locations
Other Locations
Thailand
Walailak University
RECRUITING
Nakhon Si Thammarat
Contact Information
Primary
Jakkrit Juhong, MD.
jakkrit.ju@wu.ac.th
0816773406
Time Frame
Start Date: 2024-01-01
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 142
Treatments
Active_comparator: IOLMaster 700
IOLMaster 700 represents the gold standard for measuring ocular biometry before cataract surgery, employing a single refractive index.
Experimental: ARGOS
ARGOS is a new device used to measure ocular biometry. It employs distinct refractive indices for different eye components such as the cornea, lens, and vitreous.
Related Therapeutic Areas
Sponsors
Leads: Walailak University

This content was sourced from clinicaltrials.gov